testosterone enanthate has been researched along with finasteride in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Amory, JK; Anawalt, BD; Bremner, WJ; Easley, KA; Matsumoto, AM; Sutton, PR; Tenover, JL; Watts, NB | 1 |
| Gasco, M; Gonzales, GF; Maldonado, C; Mormontoy, J; Pajuelo, M; Portella, J; Rodriguez, D; Vasquez, V; Villegas, L | 1 |
| Gasco, M; Gonzales, GF; Gonzales-Castañeda, C; Malheiros-Pereira, A | 1 |
| Cho, HH; Jeon, HC; Jo, SJ; Kwon, OS; Paik, SH | 1 |
| Beck, DT; Beggs, LA; Borst, SE; Braith, RW; Cannady, DF; Conover, CF; Lipinska, JA; Martin, JS; McCoy, SC; Meuleman, JR; Morrow, M; Nseyo, U; Roessner, S; Shuster, JJ; Yarrow, JF | 1 |
| Beck, DT; Beggs, LA; Borst, SE; Conover, CF; Meuleman, JR; Morrow, M; Shuster, JJ; Yarrow, JF; Zou, B | 1 |
| Borst, SE; Conover, CF; Fernandez, C; Meuleman, JR; Morrow, M; Shuster, JJ; Yarrow, JF; Ye, F; Zou, B | 1 |
| Aguirre, JI; Alerte, J; Bassett, TE; Borst, SE; Chen, C; Conover, CF; Flores, M; Jiron, JM; Phillips, EG; Prock, H; Teurlings, T; Vasconez, A; Yarrow, JF; Ye, F | 1 |
| Fano-Sizgorich, D; Gasco, M; Gonzales, GF; Vásquez-Velásquez, C | 1 |
4 trial(s) available for testosterone enanthate and finasteride
| Article | Year |
|---|---|
Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.
Topics: Aged; Bone Density; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Organ Size; Prostate; Prostate-Specific Antigen; Testosterone | 2004 |
Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.
Topics: Aged; Body Composition; Bone Density; Drug Therapy, Combination; Finasteride; Humans; Hypogonadism; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; Prostate; Testosterone; Treatment Outcome | 2014 |
Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone.
Topics: Aged; Aged, 80 and over; Dihydrotestosterone; Double-Blind Method; Drug Interactions; Erythrocyte Count; Erythrocytes; Ferritins; Finasteride; Humans; Iron; Male; Middle Aged; Placebos; Testosterone; Transferrin | 2014 |
Cognitive effects of testosterone and finasteride administration in older hypogonadal men.
Topics: 5-alpha Reductase Inhibitors; Aged; Androgens; Anthropometry; Chromatography, Liquid; Cognition; Enzyme-Linked Immunosorbent Assay; Finasteride; Geriatric Assessment; Humans; Hypogonadism; Male; Mass Spectrometry; Middle Aged; Muscle Strength; Testosterone; Treatment Outcome | 2014 |
6 other study(ies) available for testosterone enanthate and finasteride
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Effect of two different extracts of red maca in male rats with testosterone-induced prostatic hyperplasia.
Topics: Alcohols; Animals; Finasteride; Lepidium; Male; Organ Size; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Testosterone; Thiocyanates; Thioglucosides; Water | 2007 |
Antagonistic effect of Lepidium meyenii (red maca) on prostatic hyperplasia in adult mice.
Topics: Animals; Enzyme Inhibitors; Estradiol; Finasteride; Lepidium; Male; Mice; Phytotherapy; Prostatic Hyperplasia; Testosterone | 2008 |
Iatrogenic androgenetic alopecia in a male phenotype 46XX true hermaphrodite.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Finasteride; Humans; Male; Ovotesticular Disorders of Sex Development; Testosterone; Young Adult | 2012 |
Testosterone Plus Finasteride Prevents Bone Loss without Prostate Growth in a Rodent Spinal Cord Injury Model.
Topics: 5-alpha Reductase Inhibitors; Androgens; Animals; Bone Remodeling; Bone Resorption; Disease Models, Animal; Finasteride; Male; Muscle, Skeletal; Prostate; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Testosterone | 2017 |
Inflammatory pathway employed by Red Maca to treat induced benign prostatic hyperplasia in rats.
Topics: 5-alpha Reductase Inhibitors; Animals; Disease Models, Animal; Finasteride; Humans; Interferon-gamma; Interleukin-4; Lepidium; Male; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Signal Transduction; Testosterone; Th1 Cells; Th2 Cells; Tumor Necrosis Factor-alpha | 2020 |